ETNATM-ProgMS clinical trials

ELIOS - Investigational Biomarkers to Track Disease Modification in Active RRMS

This study, called ELIOS, is looking at new ways to track changes in relapsing-remitting multiple sclerosis (RRMS) using eye movements. It aims to see how well these eye movement tests can show if a treatment called ofatumumab is working in Canadian patients.